MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Nektar Therapeutics Company Profile (NASDAQ:NKTR)

Consensus Ratings for Nektar Therapeutics (NASDAQ:NKTR) (?)
Ratings Breakdown: 1 Sell Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $15.00 (19.24% upside)

Analysts' Ratings History for Nektar Therapeutics (NASDAQ:NKTR)
Show:
DateFirmActionRatingPrice TargetActions
6/19/2015Roth CapitalReiterated RatingBuy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/9/2015Piper JaffrayReiterated RatingOverweight$15.00 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/9/2015Brean CapitalReiterated RatingBuy$17.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/18/2015Piper JaffraySet Price TargetBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/18/2015JPMorgan Chase & Co.Lower Price TargetOverweight$19.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/18/2015Jefferies GroupLower Price TargetBuy$17.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/18/2015Brean CapitalLower Price TargetBuy$20.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/18/2015Roth CapitalLower Price TargetBuy$21.00 -> $19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/13/2015JPMorgan Chase & Co.Set Price TargetBuy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2015Brean CapitalSet Price TargetBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/26/2015Roth CapitalSet Price TargetBuy$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/17/2014Bank of AmericaReiterated RatingUnderperform$10.00 -> $11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/16/2014Brean CapitalBoost Price TargetBuy$18.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/21/2014Roth CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/11/2014Roth CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/26/2014Ladenburg ThalmannInitiated CoverageBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/13/2014MKM PartnersReiterated RatingNeutral$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/15/2014Jefferies GroupReiterated RatingBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2014Jefferies GroupReiterated RatingBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/29/2014Jefferies GroupReiterated RatingBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/21/2014Jefferies GroupInitiated CoverageBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2014MKM PartnersDowngradeBuy -> Neutral$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2014Jefferies GroupBoost Price Target$11.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2014Brean CapitalBoost Price Target$14.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/26/2013Piper JaffrayInitiated CoverageOverweight$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/30/2013JPMorgan Chase & Co.Lower Price TargetOverweight$15.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/27/2013Cowen and CompanyReiterated RatingBuy$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/27/2013Brean CapitalReiterated RatingBuy$17.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/27/2013William BlairReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/27/2013MKM PartnersLower Price TargetBuy$14.00 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/27/2013Jefferies GroupReiterated RatingHold$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/12/2013Cowen and CompanyInitiated CoverageOutperform$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/15/2013Brean CapitalBoost Price TargetBuy$14.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/4/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha